The Thoracic Surgery Division at the University of Maryland is nationally recognized for developing innovative treatments for disorders of the structures and organs of the chest, particularly the lungs and esophagus.
Disease Specialties Include:
- Esophageal Cancer
- Lung Cancer (Early & Late Stages)
- Mediastinal Tumors/Mass
- Lung Lesions/Nodules (Diagnosis)
- Lymphoma (Diagnosis)
- Pulmonary Nodule or Mass
- Barrett's Esophagus
- Reflux Disease
- Emphysema/Bullous Disease
- Hyperhidrosis (Excessive Sweating)
- Myasthenia Gravis
- Intersititial Lung Disease (ILD)
- Tracheobronchial Malacia
- Hiatal Hernia
- Thoracic Outlet Syndrome
Through novel teaching and research programs for these areas, our expert surgeon-scientists seek ways to offer patients the greatest opportunity for cure.
The division actively participates in clinical trials for both lung cancer and esophageal cancer. Current studies to which patients are currently being enrolled include CALGB 140503: an international trial studying Sublobar Resection as compared to Lobectomy for stage 1A non-small cell lung cancer. In addition, RTOG 1010 is a phase III trial evaluating the addition of Trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomas. of chemoradiation followed by esophagectomy for patients with stage 1A non-small cell lung cancer. Basic science research within the division focuses on the overexpression of survivin in gastroesophageal reflux disease, Barrett's metaplasia, and esophageal cancer (Dr. Donahue).